C5orf55 | Chromosome 5 open reading frame 55 | | | | | | Mixed |
C5orf60 | Chromosome 5 open reading frame 60 | Predicted membrane proteins
| | | | | Tissue enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAMLG | Calcium modulating ligand | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPSL | Calcyphosine-like | | | | | | Tissue enriched |
CARTPT | CART prepropeptide | FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CAST | Calpastatin | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC125 | Coiled-coil domain containing 125 | | | | | | Expressed in all |
CCDC127 | Coiled-coil domain containing 127 | | | | | | Mixed |
CCDC69 | Coiled-coil domain containing 69 | | | | | | Expressed in all |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNG1 | Cyclin G1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CCNH | Cyclin H | Cancer-related genes
| | | | | Expressed in all |
CCNI2 | Cyclin I family, member 2 | | | | | | Mixed |
CCNJL | Cyclin J-like | | | | | | Mixed |
CCT5 | Chaperonin containing TCP1, subunit 5 (epsilon) | Disease related genes Plasma proteins
| | | | | Expressed in all |
CD14 | CD14 molecule | Cancer-related genes CD markers Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CDC42SE2 | CDC42 small effector 2 | Cytoskeleton related proteins
| | | | | Expressed in all |
CDH18 | Cadherin 18, type 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH6 | Cadherin 6, type 2, K-cadherin (fetal kidney) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDHR2 | Cadherin-related family member 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDKL3 | Cyclin-dependent kinase-like 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes
| | | | | Tissue enhanced |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | | | | Group enriched |
CENPH | Centromere protein H | | | | | | Mixed |
CEP120 | Centrosomal protein 120kDa | Predicted membrane proteins
| | | | | Expressed in all |
CETN3 | Centrin, EF-hand protein, 3 | | | | | | Expressed in all |
CHD1 | Chromodomain helicase DNA binding protein 1 | Enzymes FDA approved drug targets
| | | | | Expressed in all |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
CLINT1 | Clathrin interactor 1 | Plasma proteins
| | | | | Expressed in all |
CLTB | Clathrin, light chain B | Plasma proteins
| | | | | Expressed in all |
CMBL | Carboxymethylenebutenolidase homolog (Pseudomonas) | | | | | | Expressed in all |
COL23A1 | Collagen, type XXIII, alpha 1 | | | | | | Tissue enhanced |
COL4A3BP | Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | | | | | | Expressed in all |
COMMD10 | COMM domain containing 10 | | | | | | Expressed in all |
COX7C | Cytochrome c oxidase subunit VIIc | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CPEB4 | Cytoplasmic polyadenylation element binding protein 4 | | | | | | Expressed in all |
CRHBP | Corticotropin releasing hormone binding protein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSF1R | Colony stimulating factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
CSNK1G3 | Casein kinase 1, gamma 3 | Enzymes
| | | | | Expressed in all |
CTD-2260A17.2 | Uncharacterized protein | | | | | | Tissue enhanced |